openPR Logo
Press release

Bacterial Disease Diagnostic Market to Witness an Outstanding Growth by 2023

06-08-2017 03:27 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Bacterial Disease Diagnostic Market to Witness an Outstanding

Bacteria are of various types some of them are infectious whereas, majority of them are beneficial for the body. Any bacteria that cause an infectious disease are called pathogens. Diagnosis of causative organism of a bacterial disease has always been difficult, since infections show similar symptoms like fever and lethargy. Routine clinical diagnosis have high error rate, administering the wrong antibiotics can sometimes increase infection and can even result in death. The oldest method for diagnosis has been culturing of bacteria, these cultures allow only specific species to grow in the medium, however this method is very time consuming and can seldom be done on time to successfully diagnose and treat the patient. Newer techniques like rapid culture methods with ionized mass spectrometry are currently in use for diagnosing some rare bacteria.

Browse through Bacterial Disease Diagnostic Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/bacterial-disease-diagnostic-market.html

Currently, PCR (Polymerase Chain Reaction) sequencer is the most favored and well know method. The PCR can amplify bacterial DNA a thousand times if necessary, any routine diagnosis requires only a min of 10 – 80 bacteria, which means PCR has a very high sensitivity. This factor is exploited for countless diagnostic processes. PCR also doesn’t require purification of the bacterial sample compared to older methods as it has specific sequences to identify bacterial DNA. Versatility of PCR has proven to be a big advantage, diagnosis of many dangerous diseases like tuberculosis, pneumonia etc are done with the intention to specify whether the strain is drug resistant. This greatly increases the success rate of treatment. The shortcomings of PCR are also eminent; PCR is susceptible to false positive report in presence of any contamination, it is also not useful in calculating the success of a treatment, as PCR recognizes dead and living cells as the same. Technical expertise is a major requirement in PCR handling. PCR techniques also require a number of biochemical reagents that are quite expensive. Development has been made to create more specific and customized versions of PCR machines with greater accuracy and low false positive rates. These include; PCR ribotyping techniques which are much faster and highly specific to certain strains; multiplex PCR that can detect multiple pathogens in a single go and nested PCR a modified error negating version of PCR. Such modified versions are currently available in laboratories and are offered as a diagnostic service and are seldom used as a large-scale diagnostic tool. However, with the entry of novel ‘portable PCR’ there is a scope for diagnostic evolution in future.

On the other hand, scientists throughout the world are developing ideas in Electrophoresis methods and tests for biological proteins that are produced in the body in reaction to an infection. In newborns such tests are done to investigate the diseases that have late onset period. With increasing population and globalization, the chance of infection remains high, diseases too have gone global. In addition, diagnosing a disease before it becomes an epidemic is very critical. Thus, PCR and electrophoresis machines helps in early and fast diagnosis of these diseases that leads to an increase in the demand for PCR and electrophoresis machines. However, lack of skilled professionals/technicians and high cost of these devices restricts the overall growth of bacterial disease diagnostics market.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Bacterial Disease Diagnostic Market by 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7823

Some of the companies that produce PCR machines are Techne, GeneriBiotech, Roche diagnostics and ZyGEM to name a few. The sales of these devices are currently highest in the developed nations of the North Americas and Europe whereas, Asia-Pacific region shows the highest growth followed by South America and Africa.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Disease Diagnostic Market to Witness an Outstanding Growth by 2023 here

News-ID: 570434 • Views: …

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…

All 5 Releases


More Releases for PCR

PCR & Real-time PCR Molecular Diagnostics Market Size to Expand Lucratively duri …
PCR & Real-time PCR Molecular Diagnostics Market: Introduction Transparency Market Research has published a new report titled, 'Global PCR & Real-time PCR Molecular Diagnostics Market'. According to the report, the global PCR & real-time PCR molecular diagnostics market was valued over US$ 4.1 Bn in 2019. It is projected to expand at a CAGR of ~4% from 2020 to 2030. Polymerase chain reaction (PCR) is used to amplify or make copies…
04-23-2021 | Health & Medicine
Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market – Outlook, Size, Share & Fo …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular…
Global Real-time PCR (RT-PCR) Fluorescence Probe Market Growth 2020-2025
GLOBAL INFO RESEARCH has lately published a new report titled, *Global and China Real-time PCR (RT-PCR) Fluorescence Probe Market 2020 by Company, Type and Application, Forecast to 2025*. The researchers have offered a broad understanding of the industry with the help of research methodologies such as PESTLE Analysis and Porter's Five Forces. Click to view the full report TOC, figure and tables:  https://www.globalinforesearch.com/Global-Real-time-PCR-(RT-PCR)-Fluorescence-Probe_p418256.html At the start, the report lays emphasis on the key…
PCR Technologiess Market 2027 By Companies(Abbott, F. Hoffmann-La Roche Ltd., Th …
The exclusive report on PCR Technologies Market research report has been formulated with the help of extensive primary research (inputs from industry experts, companies, and stakeholders) and secondary research to get a universal view of the market. The report gives an in-detailed information across global regions, including North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South America & Central America (SCAM). We follow an iterative research…
Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Intelligence Report Offers …
Polymerase chain reaction (PCR) technology is used to amplify or make several copies of deoxyribonucleic acid (DNA) sequence of interest. Polymerase chain reaction (PCR) technology is used in various applications ranging from DNA cloning, diagnosis of hereditary diseases, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences. Digital PCR (dPCR) and quantitative PCR (qPCR) are two major types of polymerase chain reaction (PCR) technologies. Digital PCR…
United States Digital PCR and Real-time PCR (qPCR) Market Report 2017
24 Market Reports provides a complete data analysis of United States Digital PCR and Real-time PCR (qPCR) Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the United States Digital PCR and Real-time PCR (qPCR) market is expected to reach high by the end of 2022. Geographically, this report splits the United States market into seven regions: • The West • Southwest • The Middle Atlantic • New…